Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > It's nice to see someone with experience in charge now
View:
Post by bailmeout on Jul 23, 2014 10:54am

It's nice to see someone with experience in charge now

Michael J. Berendt, Ph.D., 65, has served as a Director of the Company since March 1998. Dr. Berendt is the Chief Executive Officer and a Director of Bioniche Lifesciences Inc., a position he assumed in November 2013. From July 2011 to November 2013, Dr. Berendt was a Life Sciences Consultant. From March 2006 to July 2011, Dr. Berendt served as the President and Chief Executive Officer of Aegera Therapeutics Inc. From August 2004 to December 2005, Dr. Berendt served as Managing Director of Research Corporation Technologies. From November 2000 to August 2004, Dr. Berendt served as Managing Director of AEA Investors. Dr. Berendt also worked for 18 years, from 1982 to 2000, in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation, and a Group Director of Drug Discovery at Pfizer, Inc. Dr. Berendt has served as a director of Onyx Pharmaceuticals, Myriad Genetics, Inc., Catalyst Biosciences and Northstar Neuroscience.
Comment by whitemagj on Jul 23, 2014 11:01am
This post has been removed in accordance with Community Policy
Comment by NoNukNuk on Jul 23, 2014 12:57pm
Berendt a director of BNC since 1998??  I think you are mistaken. 
Comment by bailmeout on Jul 23, 2014 1:08pm
Sorry that was probably talking about Water Corp..it was from forbes magazine..cut and paste. It was the rest I was interested in :)
Comment by ragingbull1327 on Jul 23, 2014 1:21pm
He was an advisor for years..... 
Comment by bailmeout on Jul 23, 2014 1:33pm
Like I said it's nice to see someone with experience in charge now.. :) Advisors can't help if they aren't listened to..kind of like shareholders...
Comment by ragingbull1327 on Jul 23, 2014 2:33pm
So, the "street" is always right?   Your company is worth LESS now, with next to no debt, no more funding on trials, no more Animal Health, than when Endo gave the rights back?   Wow.  
Comment by NoNukNuk on Jul 23, 2014 7:18pm
Worth more or less with Animal Health gone?  AH did bring in revenue and make money on its own.  Actually this company has a track record of selling off the assets it has developed from scratch that go on to become successful enterprises.   Kudos to BNC, lets see you sell econiche and the VMC just before the world decides ecoli vaccinations for runimants makes burgers better than ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities